Agado Live

AI platform empowering neurological PTs to treat more patients with the same staff

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2021 by Tzach Goren, Gili Yaron, and Vittaly Tavor, Agado Live operates with 11–50 employees. The company has secured funding across two rounds, with a notable grant received from the BIRD Foundation in July 2023.

Business overview

Agado Live develops an end-to-end solution leveraging AI and computer vision to enable neurological physical therapists to conduct real-time sessions with multiple patients simultaneously, without compromising service quality. The company's core technology empowers therapists to efficiently treat a larger patient population, serving the healthcare and life sciences industries. Agado Live operates within the Health Tech & Life Sciences sector, focusing on artificial intelligence, machine learning, and computer vision technologies.

Company Intelligence Q&A

What is Agado Live's primary focus?
Agado Live focuses on empowering neurological physical therapists with an AI platform to treat more patients efficiently while maintaining high-quality care.
When was Agado Live founded?
Agado Live was founded in January 2021.
Who are the founders of Agado Live?
Agado Live was co-founded by Tzach Goren, Gili Yaron, and Vittaly Tavor.
Which markets does Agado Live target?
Agado Live targets the Americas, Global, and Europe markets with its solutions.